Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM et al Acromegaly. Nat Rev Dis Prim 2019 51 [Internet]. 2019 Mar 21 [cited 2022 Sep 8];5(1):1–17. Available from: https://www.nature.com/articles/s41572-019-0071-6
2. Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al A Pituitary Society update to acromegaly management guidelines. Pituitary [Internet]. 2021 Feb 1 [cited 2022 Sep 8];24(1):1. Available from: https://www.pmc/articles/PMC7864830/
3. Strasburger CJ, Karavitaki N, Stormann S, Trainer PJ, Kreitschmann-Andermahr I, Droste M et al Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly. Eur J Endocrinol [Internet]. 2016 Mar 1 [cited 2022 Sep 8];174(3):355. Available from: http://www.pmc/articles/PMC4722610/
4. Johnson MD, Woodburn CJ, Lee Vance M Quality of Life in Patients with a Pituitary Adenoma. Pituit 2003 62 [Internet]. 2003 [cited 2022 Oct 11];6(2):81–7. Available from: https://link.springer.com/article/10.1023/B:PITU0000004798.27230.ed
5. Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C et al (2017) Predictors of quality of life in acromegaly: No consensus on biochemical parameters. Front Endocrinol (Lausanne) [Internet]. Mar 3 [cited 2022 Oct 11];8(MAR):40. Available from: http://www.pmc/articles/PMC5334635/